Related references
Note: Only part of the references are listed.Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis
M. Veltkamp et al.
TISSUE ANTIGENS (2012)
Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2
C. Abad et al.
GENES AND IMMUNITY (2011)
A Nonsynonymous Polymorphism of IRAK4 Associated with Increased Prevalence of Gram-Positive Infection and Decreased Response to Toll-Like Receptor Ligands
Ainsley M. Sutherland et al.
JOURNAL OF INNATE IMMUNITY (2011)
Sequence Variants in the TLR4 and TLR6-1-10 Genes and Prostate Cancer Risk. Results Based on Pooled Analysis from Three Independent Studies
Sara Lindstroem et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans
Digna Rosa Velez et al.
HUMAN GENETICS (2010)
The toll-like receptor 1 variant S248N influences placental malaria
Lutz Hamann et al.
INFECTION GENETICS AND EVOLUTION (2010)
Human TLRs 10 and 1 Share Common Mechanisms of Innate Immune Sensing but Not Signaling
Yue Guan et al.
JOURNAL OF IMMUNOLOGY (2010)
Data quality control in genetic case-control association studies
Carl A. Anderson et al.
NATURE PROTOCOLS (2010)
Common Variants of TLR1 Associate with Organ Dysfunction and Sustained Pro-Inflammatory Responses during Sepsis
Maria Pino-Yanes et al.
PLOS ONE (2010)
Leprosy and the Adaptation of Human Toll-Like Receptor 1
Sunny H. Wong et al.
PLOS PATHOGENS (2010)
A Unified Approach to Genotype Imputation and Haplotype-Phase Inference for Large Data Sets of Trios and Unrelated Individuals
Brian L. Browning et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma
Mark P. Purdue et al.
CARCINOGENESIS (2009)
Toll-Like Receptor Polymorphisms and Susceptibility to Urinary Tract Infections in Adult Women
Thomas R. Hawn et al.
PLOS ONE (2009)
The Heterogeneous Allelic Repertoire of Human Toll-Like Receptor (TLR) Genes
Philippe Georgel et al.
PLOS ONE (2009)
Evolutionary Dynamics of Human Toll-Like Receptors and Their Different Contributions to Host Defense
Luis B. Barreiro et al.
PLOS GENETICS (2009)
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis
Mark M. Wurfel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk
Victoria L. Stevens et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Toll-like receptor heterodimer variants protect from childhood asthma
Michael S. D. Kormann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis
Salima Mrabet-Dahbi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Full-Exon Resequencing Reveals Toll-Like Receptor Variants Contribute to Human Susceptibility to Tuberculosis Disease
Xin Ma et al.
PLOS ONE (2007)
Association between toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer
Yen-Ching Chen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy
Christopher M. Johnson et al.
JOURNAL OF IMMUNOLOGY (2007)
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis
Chiea C. Khor et al.
NATURE GENETICS (2007)
Variant IRAK-1 haplotype is associated with increased nuclear factor-κB activation and worse outcomes in sepsis
John Arcaroli et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Toll-like receptor-1,-2, and-6 polymorphisms influence disease extension in inflammatory bowel diseases
M Pierik et al.
INFLAMMATORY BOWEL DISEASES (2006)
Identification of high and low responders to lipopolysaccharide in normal subjects: An unbiased approach to identify modulators of innate immunity
MM Wurfel et al.
JOURNAL OF IMMUNOLOGY (2005)
Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88
U Hasan et al.
JOURNAL OF IMMUNOLOGY (2005)
Toll-like receptor 2 is required for optimal control of Listelia monocytogenes infection
D Torres et al.
INFECTION AND IMMUNITY (2004)
Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6
T Okusawa et al.
INFECTION AND IMMUNITY (2004)
TOLL-like receptor 10 genetic variation is associated with asthma in two independent samples
R Lazarus et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection
MB Drennan et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Direct binding of toll-like receptor 2 to zymosan, and zymosan-induced NF-κB activation and TNF-α secretion are down-regulated by lung collectin surfactant protein A
M Sato et al.
JOURNAL OF IMMUNOLOGY (2003)
Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation
H Echchannaoui et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins
O Takeuchi et al.
JOURNAL OF IMMUNOLOGY (2002)
Toll-like receptors: critical proteins linking innate and acquired immunity
S Akira et al.
NATURE IMMUNOLOGY (2001)
Discrimination of bacterial lipoproteins by Toll-like receptor 6
O Takeuchi et al.
INTERNATIONAL IMMUNOLOGY (2001)
Cutting edge:: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection
O Takeuchi et al.
JOURNAL OF IMMUNOLOGY (2000)
Structural basis for signal transduction by the Toll/interleukin-1 receptor domains
YW Xu et al.
NATURE (2000)
Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2-and MyD88-dependent signaling pathway
O Takeuchi et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
